A Study Assessing the Safety and Efficacy of Multiple Intravitreal KH902 in Patients With CNV Due to AMD

NCT01242254 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Neovascular Age-related Macular Degeneration

Interventions

BIOLOGICAL: Intravitreal injection of KH902

Sponsor

Chengdu Kanghong Biotech Co., Ltd.

Collaborators

[object Object]
[object Object]